Здоровье
Препарат Бристоль Майерс для лечения заболеваний кишечника не прошел позднюю стадию испытаний
Bristol Myers Squibb said Thursday that its experimental drug to treat Crohn’s disease, a chronic inflammatory bowel disease, failed to help patients achieve remission of
Президент Польши приостановил принятие законопроекта об облегчении доступа к таблеткам, принимаемым на следующее утро
Polish President Andrzej Duda vetoed a bill to make the morning-after contraceptive pill more accessible to women, sparking outrage among liberal and left-wing politicians. Some
FDA США одобрило препарат Akebia от анемии
The US Food and Drug Administration has approved Akebia Therapeutics’ drug vadadustat for the treatment of anaemia caused by chronic kidney disease (CKD) in patients
UnitedHealth Group выплатила поставщикам медицинских услуг более $3,3 млрд.
U.S. insurer UnitedHealth Group said on Wednesday it has so far provided more than $3.3 billion to healthcare providers affected by last month’s cyberattack on
J&J может опровергнуть доказательства, связывающие ее тальк с раком
Johnson & Johnson will have a new opportunity to rebut scientific evidence linking its talc to ovarian cancer, a federal judge ruled, potentially altering the
FDA США одобрило терапию Merck для лечения редких заболеваний легких
The U.S. Food and Drug Administration on Tuesday approved Merck’s drug treatment for adults with high blood pressure due to narrowing of the pulmonary arteries,
Таблетка для похудения Viking Therapeutics показала многообещающие результаты в небольшом исследовании
Viking Therapeutics An experimental pill reduced weight by as much as 3.3% when tested on volunteers in a small early trial, meeting Wall Street’s expectations
Япония предупреждает о росте потенциально смертельных случаев ангины
Health authorities in Japan have warned of a sharp rise in potentially fatal sore throat infections, with the number of cases in Tokyo about three
AbbVie усилит производство лекарств от иммунных заболеваний благодаря сделке с Lando
AbbVie will buy drug developer Landos Biopharma for up to $212 million as the Humira maker seeks to expand its line of medicines to treat
Лечение рака крови Regeneron сталкивается с неудачей
Regeneron Pharmaceuticals said Monday that the U.S. FDA has rejected approval for a blood cancer treatment for two forms of lymphoma because of concerns about